What is Qiagen NV Quarterly Revenue?

Qiagen NV Quarterly Revenue Qiagen NV Dec-2024 Quarterly Revenue is $521 Million which is growth of 2.4% YoY.

What is Qiagen NV Quarterly Net Profit?

Qiagen NV Quarterly Net Profit Qiagen NV Dec-2024 Quarterly Net Profit is $88 Million which is growth of -9.6% YoY.

What is Qiagen NV Annual Revenue?

Qiagen NV Annual Revenue Qiagen NV Dec-2024 Annual Revenue is $1,978 Million which is growth of 0.7% YoY.

What is Qiagen NV Annual Net Profit?

Qiagen NV Annual Net Profit Qiagen NV Dec-2024 Annual Net Profit is $84 Million which is growth of -75.5% YoY.

What is Qiagen NV Total Shareholders Fund?

Qiagen NV Total Shareholders Fund Qiagen NV Dec-2024 Total Shareholders Fund is $3,567 Million which is growth of -6.3% YoY.

What is Qiagen NV Total Assets?

Qiagen NV Total Assets Qiagen NV Dec-2024 Total Assets is $5,690 Million which is growth of -7.0% YoY.

What is Qiagen NV Book Value Per Share?

Qiagen NV Book Value Per Share Qiagen NV Book Value Per Share is $17 which is growth of -3.8% YoY.

What is Qiagen NV ROE?

Qiagen NV ROE Qiagen NV ROE is 2% which is growth of 7.1% YoY.

What is Qiagen NV Cash From Operating Activity?

Qiagen NV Cash From Operating Activity Qiagen NV Dec-2024 Cash From Operating Activity is $674 Million which is growth of 46.6% YoY.

What is Qiagen NV Net Cash Flow?

Qiagen NV Net Cash Flow Qiagen NV Dec-2024 Net Cash Flow is $1 Million which is growth of 102.3% YoY.

What is Qiagen NV Annual Revenue?

Qiagen NV Annual Revenue rose 0.66%, in the last year to $1,978.21 M. Its sector's average revenue growth for the last fiscal year was 8.57%.

What is Qiagen NV Annual Net Profit?

Qiagen NV Annual Net Profit fell 75.51% in the last year to $83.59 M. Its sector's average net profit growth for the last fiscal year was 4.36%.

What is Qiagen NV Price to Earning Ratio?

Qiagen NV Price to Earning Ratio is 105.25, higher than its sector PE ratio of 29.09.

What is Qiagen NV Stock Price?

Qiagen NV Stock Price fell 1.05% and underperformed its sector by 6.48% in the past year.

What is Qiagen NV Quarterly Revenue?

Qiagen NV Quarterly Revenue rose 2.36% YoY to $521.2 M. Its sector's average revenue growth YoY for the quarter was 8.5%.

What is Qiagen NV Quarterly Net profit?

Qiagen NV Quarterly Net profit fell 9.57% YoY to $88.32 M. Its sector's average net profit growth YoY for the quarter was 32.89%.

What is Qiagen NV Debt to Equity Ratio?

Qiagen NV Debt to Equity Ratio of 0.4 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Qiagen NV Return on Equity(ROE)?

Qiagen NV Return on Equity(ROE) for the last financial year was 2.27%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Qiagen NV Mutual Fund Holding?

Qiagen NV Mutual Fund Holding increased by 0.61% in the last quarter to 68.88.

What is Qiagen NV Interest Coverage Ratio?

Qiagen NV Interest Coverage Ratio is 3.76, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).

What is Qiagen NV Institutional Holding?

Qiagen NV Institutional Holding increased by 0.05% in the last quarter to 64.4.

How is the Qiagen NV today?

The Qiagen NV today is trading in the down by -1.76% at 40.71.

How has Qiagen NV performed historically?

The Qiagen NV is currently trading down -1.76% on an intraday basis in the past week the index fell -3.03%. The index has been down -13.95% in the past quarter and fell -1.05% in the past year. You can view this in the overview section.

Qiagen NV XNYS: QGEN

Qiagen NV Live Share Price Today, Share Analysis and Chart

Name: Qiagen NV: Is Infosys Ltd. worth buying?
Item: Qiagen NV
Rating: 2.228291625
Author: Trendlyne DVM scores

Expensive Performer

Download real time

40.71 -0.73 (-1.76%)

1.7M XNYS Volume

XNYS 17 Apr, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Qiagen NV is on 30 Apr 2025 for the purpose of Qiagen NV First Quarter Earnings Conference Call for 2025 See details

Qiagen NV Key Metrics

My Metrics

Select

Market Capitalization High in industry Unavailable in chosen country	8,798.1
PE TTM High in industry Unavailable in chosen country	105.3
PEG TTM Negative PEG TTM Unavailable in chosen country	-1.4
Price to Book Below industry Median Unavailable in chosen country	2.5
Institutional holding current Qtr % Below industry Median Unavailable in chosen country	64.4
Revenue Growth Qtr YoY % Below industry Median Unavailable in chosen country	2.4
Operating Revenue growth TTM % Below industry Median Unavailable in chosen country	0.7
Net Profit Qtr Growth YoY % Negative Net Profit Qtr Growth YoY % Unavailable in chosen country	-9.6
Net Profit TTM Growth % Negative Net Profit TTM Growth % Unavailable in chosen country	-75.5
Operating Profit Margin Qtr % High in industry Unavailable in chosen country	27.1
Operating Profit Margin TTM % Below industry Median Unavailable in chosen country	10.1
Piotroski Score High in industry Unavailable in chosen country	6
Rel Perf vs Sector quarter% Unavailable in chosen country	-6.7
ROE Annual % Below industry Median Unavailable in chosen country	2.3
RoA Annual % Below industry Median Unavailable in chosen country	1.4

All financials are in USD Million and price data in USD

Medium Financial Strength

50.0 / 100

Expensive Valuation

29.3 / 100

Technically Neutral

48.9 / 100

Expensive Performer These stocks are with medium quality and mid-range technical aspects. However, their financials make them little expensive so choose the right moment to buy them. View Similar Embed DVM

1Yr Price target upside is 21%

16 analysts

Check Before You Buy

Check P/E Buy Sell Zone

Strong Sell Zone

85.0 % into P/E buy sell zone

Strong upside potential

% time spent below current P/E

Gains already realized

Qiagen NV Stock Price Analysis

Day Price Range -1.8% 1 Day return Unavailable in chosen country	40.7 (LTP) 4041.1 LowHigh
Week Price Range -3.0% 1 Week return Unavailable in chosen country	40.7 (LTP) 4043.9 LowHigh
Month Price Range 2.7% 1 Month return Unavailable in chosen country	40.7 (LTP) 38.143.9 LowHigh
52 Week Price Range -1.0% 1 Year return Unavailable in chosen country	40.7 (LTP) 37.649.3 LowHigh

View full Share Price History

Qiagen NV Live Price Chart

Switch to TradingView

Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Hit

Qiagen NV's Revenue was higher than average estimate 2 times in past 3 years

EPS forecast

QUARTER
ANNUAL

Current EPS

0.4

Avg. Estimate

Low Estimate

1.8

High Estimate

2.4

Current EPS

Avg. Estimate

Hit

EPS is expected to grow by 451.4% in FY25

Consensus Recommendation

17 ANALYST Recommendations

BUY

The consensus recommendation from 17 analysts for Qiagen NV is BUY

Forecaster is a Premium Feature

You need to upgrade your subscription plan to access this feature

Upgrade Now

Qiagen NV Stock Analysis

Qiagen NV stock analysis with key metrics, changes, and trends.

Qiagen NV Metric	VALUE	CHANGE %	TREND	ANALYSIS
Annual Revenue	$1,978.21 M	0.66%	positive	Annual Revenue rose 0.66%, in the last year to $1,978.21 M. Its sector's average revenue growth for the last fiscal year was 8.57%.
Annual Net Profit	$83.59 M	75.51%	negative	Annual Net Profit fell 75.51% in the last year to $83.59 M. Its sector's average net profit growth for the last fiscal year was 4.36%.
Price to Earning Ratio	105.25	-	negative	Price to Earning Ratio is 105.25, higher than its sector PE ratio of 29.09.
Stock Price	$40.71	-1.05%	negative	Stock Price fell 1.05% and underperformed its sector by 6.48% in the past year.
Quarterly Revenue	$521.2 M	2.36%	positive	Quarterly Revenue rose 2.36% YoY to $521.2 M. Its sector's average revenue growth YoY for the quarter was 8.5%.
Quarterly Net profit	$88.32 M	9.57%	negative	Quarterly Net profit fell 9.57% YoY to $88.32 M. Its sector's average net profit growth YoY for the quarter was 32.89%.
Debt to Equity Ratio	0.4	-	positive	Debt to Equity Ratio of 0.4 is less than 1 and healthy. This implies that its assets are financed mainly through equity.
Return on Equity(ROE)	2.27 %	2.27%	negative	Return on Equity(ROE) for the last financial year was 2.27%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.
Mutual Fund Holding	68.88 %	0.61%	positive	Mutual Fund Holding increased by 0.61% in the last quarter to 68.88.
Interest Coverage Ratio	3.76	-	positive	Interest Coverage Ratio is 3.76, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).
Institutional Holding	64.40 %	0.05%	positive	Institutional Holding increased by 0.05% in the last quarter to 64.4.

VIEW LESS

Loading data..

Qiagen NV - Company Profile

What does Qiagen NV do?

Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).

Qiagen NV Management structure

All Gross Remunerations are in USD

Mr. Roland Sackers

Managing Director and Chief Financial Officer

2.33 M

2024

Gross Remuneration

Year

Mr. Thierry Bernard

Managing Director and Chief Executive Officer

1.49 M

2024

86.56 K

2024

Gross Remuneration

Year

Qiagen NV Live Share Price Today, Share Analysis and Chart

Qiagen NV Key Metrics

Market Capitalization

PE TTM

PEG TTM

Rel Perf vs Sector quarter%

Price to Book

Institutional holding current Qtr %

Revenue Growth Qtr YoY %

ROE Annual %

Operating Revenue growth TTM %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

RoA Annual %

Operating Profit Margin Qtr %

Operating Profit Margin TTM %

Piotroski Score

Market Capitalization

PE TTM

PEG TTM

Price to Book

Institutional holding current Qtr %

Revenue Growth Qtr YoY %

Operating Revenue growth TTM %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

Operating Profit Margin Qtr %

Operating Profit Margin TTM %

Piotroski Score

Rel Perf vs Sector quarter%

ROE Annual %

RoA Annual %

SWOT Analysis

Check Before You Buy

Check P/E Buy Sell Zone

Qiagen NV Stock Price Analysis

Day Price Range

Week Price Range

Month Price Range

52 Week Price Range

Qiagen NV Live Price Chart

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Qiagen NV's Revenue was higher than average estimate 2 times in past 3 years

EPS forecast

EPS is expected to grow by 451.4% in FY25

Consensus Recommendation

The consensus recommendation from 17 analysts for Qiagen NV is BUY

Qiagen NV Stock Analysis

Qiagen NV stock analysis with key metrics, changes, and trends.

Annual Revenue rose 0.66%, in the last year to $1,978.21 M. Its sector's average revenue growth for the last fiscal year was 8.57%.

Annual Net Profit fell 75.51% in the last year to $83.59 M. Its sector's average net profit growth for the last fiscal year was 4.36%.

Price to Earning Ratio is 105.25, higher than its sector PE ratio of 29.09.

Stock Price fell 1.05% and underperformed its sector by 6.48% in the past year.

Quarterly Revenue rose 2.36% YoY to $521.2 M. Its sector's average revenue growth YoY for the quarter was 8.5%.

Quarterly Net profit fell 9.57% YoY to $88.32 M. Its sector's average net profit growth YoY for the quarter was 32.89%.

Debt to Equity Ratio of 0.4 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

Return on Equity(ROE) for the last financial year was 2.27%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

Mutual Fund Holding increased by 0.61% in the last quarter to 68.88.

Interest Coverage Ratio is 3.76, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).

Institutional Holding increased by 0.05% in the last quarter to 64.4.

Qiagen NV - Company Profile

What does Qiagen NV do?

Qiagen NV Management structure

Mr. Roland Sackers

Managing Director and Chief Financial Officer

Mr. Thierry Bernard

Managing Director and Chief Executive Officer

Qiagen NV Board of directors

Mr. Lawrence A. Rosen

Chairman of the Supervisory Board

Ms. Elizabeth E. Tallett

Member of the Supervisory Board

Dr. Metin Colpan

Member of the Supervisory Board

Mr. Toralf Haag PhD

Member of the Supervisory Board

Mr. Stephen H. Rusckowski

Member of the Supervisory Board

Dr. Elaine R. Mardis, PhD